Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

NCT02948140 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT02948140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02948140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Terminated
Start date
June 13, 2016
Completion date
December 31, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke